US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 13.300
  • +0.940+7.61%
Close Feb 28 16:00 ET
  • 13.300
  • 0.0000.00%
Post 16:05 ET
723.73MMarket Cap-12.17P/E (TTM)

Bicara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.54%-17.22M
-42.25%-45.63M
-8.04M
-10.53M
-32.08M
Net income from continuing operations
23.48%-17.48M
-37.36%-51.99M
---12.44M
---22.85M
---37.85M
Depreciation and amortization
650.00%15K
90.00%19K
--14K
--2K
--10K
Other non cash items
-99.49%68K
--13.5M
--113K
--13.35M
----
Change In working capital
-18.89%-1.86M
-294.46%-9.62M
--2.94M
---1.56M
--4.95M
-Change in prepaid assets
-532.00%-108K
0.87%-914K
---59K
--25K
---922K
-Change in payables and accrued expense
-6.14%-1.68M
-247.56%-8.66M
--3.04M
---1.58M
--5.87M
-Change in other current liabilities
-928.57%-72K
---47K
---40K
---7K
--0
Cash from discontinued investing activities
Operating cash flow
-63.54%-17.22M
-42.25%-45.63M
---8.04M
---10.53M
---32.08M
Investing cash flow
Cash flow from continuing investing activities
94.67%-8K
-205.21%-586K
-436K
-150K
-192K
Net PPE purchase and sale
94.67%-8K
-205.21%-586K
---436K
---150K
---192K
Cash from discontinued investing activities
Investing cash flow
94.67%-8K
-205.21%-586K
---436K
---150K
---192K
Financing cash flow
Cash flow from continuing financing activities
737.39%334.14M
759.74%272.5M
194.7M
39.9M
31.7M
Net preferred stock issuance
--0
763.63%272.35M
--194.7M
--39.82M
--31.54M
Proceeds from stock option exercised by employees
-28.57%60K
-6.88%149K
--0
--84K
--160K
Cash from discontinued financing activities
Financing cash flow
737.39%334.14M
759.74%272.5M
--194.7M
--39.9M
--31.7M
Net cash flow
Beginning cash position
1,259.94%203.86M
-12.11%4.16M
--44.21M
--14.99M
--4.73M
Current changes in cash
984.54%316.9M
39,590.75%226.28M
--186.23M
--29.22M
---573K
End cash Position
1,077.92%520.76M
5,442.09%230.44M
--230.44M
--44.21M
--4.16M
Free cash flow
-61.32%-17.23M
-43.22%-46.21M
---8.47M
---10.68M
---32.27M
Currency Unit
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.54%-17.22M-42.25%-45.63M-8.04M-10.53M-32.08M
Net income from continuing operations 23.48%-17.48M-37.36%-51.99M---12.44M---22.85M---37.85M
Depreciation and amortization 650.00%15K90.00%19K--14K--2K--10K
Other non cash items -99.49%68K--13.5M--113K--13.35M----
Change In working capital -18.89%-1.86M-294.46%-9.62M--2.94M---1.56M--4.95M
-Change in prepaid assets -532.00%-108K0.87%-914K---59K--25K---922K
-Change in payables and accrued expense -6.14%-1.68M-247.56%-8.66M--3.04M---1.58M--5.87M
-Change in other current liabilities -928.57%-72K---47K---40K---7K--0
Cash from discontinued investing activities
Operating cash flow -63.54%-17.22M-42.25%-45.63M---8.04M---10.53M---32.08M
Investing cash flow
Cash flow from continuing investing activities 94.67%-8K-205.21%-586K-436K-150K-192K
Net PPE purchase and sale 94.67%-8K-205.21%-586K---436K---150K---192K
Cash from discontinued investing activities
Investing cash flow 94.67%-8K-205.21%-586K---436K---150K---192K
Financing cash flow
Cash flow from continuing financing activities 737.39%334.14M759.74%272.5M194.7M39.9M31.7M
Net preferred stock issuance --0763.63%272.35M--194.7M--39.82M--31.54M
Proceeds from stock option exercised by employees -28.57%60K-6.88%149K--0--84K--160K
Cash from discontinued financing activities
Financing cash flow 737.39%334.14M759.74%272.5M--194.7M--39.9M--31.7M
Net cash flow
Beginning cash position 1,259.94%203.86M-12.11%4.16M--44.21M--14.99M--4.73M
Current changes in cash 984.54%316.9M39,590.75%226.28M--186.23M--29.22M---573K
End cash Position 1,077.92%520.76M5,442.09%230.44M--230.44M--44.21M--4.16M
Free cash flow -61.32%-17.23M-43.22%-46.21M---8.47M---10.68M---32.27M
Currency Unit USDUSDUSDUSDUSD

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025